An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference
Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a company focused on spinal cord injury treatment, announced the participation of CEO Richard Toselli at the H.C. Wainwright Annual Global Investment Conference from September 13-15, 2021. The conference will be virtual, and a webcast of the presentation will be available on the company's Investor Relations page starting on September 13 at 7:00 am ET. Additionally, Dr. Toselli will engage in one-on-one meetings with registered investors during the event.
Positive
None.
Negative
None.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--
InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced that Richard Toselli, M.D., President and Chief Executive Officer, will present at the upcoming H.C. Wainwright Annual Global Investment Conference, which runs from September 13 – 15, 2021. The conference will be held in a virtual format.
A webcast of Dr. Toselli’s presentation will be available on the Investor Relations - Events section of the company website at https://investors.invivotherapeutics.com/events, beginning September 13, 2021 at 7:00 am ET. Dr. Toselli and company management will also be available to participate in one-on-one meetings with investors who are registered to attend the conference.
About InVivo Therapeutics
InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The company was founded in 2005 with proprietary technology co-invented by Robert Langer, Sc.D., Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, M.D., who then was at Boston Children’s Hospital and who now is affiliated with Massachusetts General Hospital. The publicly traded company is headquartered in Cambridge, MA. For more details, visit www.invivotherapeutics.com.
What is InVivo Therapeutics announcing regarding the Global Investment Conference?
InVivo Therapeutics is announcing the participation of CEO Richard Toselli at the H.C. Wainwright Annual Global Investment Conference from September 13-15, 2021, with a webcast available on their Investor Relations page.
When will the webcast of Dr. Toselli's presentation be available?
The webcast of Dr. Toselli's presentation will be available starting September 13, 2021, at 7:00 am ET.
Where can I find more information on the Global Investment Conference?
More information on the Global Investment Conference can be found on InVivo Therapeutics' Investor Relations webpage.
